These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17335333)

  • 1. The psychopharmacology of violence with emphasis on schizophrenia, part 2: long-term treatment.
    Citrome L
    J Clin Psychiatry; 2007 Feb; 68(2):331-2. PubMed ID: 17335333
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of violence in schizophrenia and implications for long-term treatment.
    Volavka J; Citrome L
    Int J Clin Pract; 2008 Aug; 62(8):1237-45. PubMed ID: 18564202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological management of human violence.
    Itil TM; Mukhopadhyay S
    Mod Probl Pharmacopsychiatry; 1978; 13():139-58. PubMed ID: 24173
    [No Abstract]   [Full Text] [Related]  

  • 4. Aggression and schizophrenia: efficacy of risperidone.
    Buckley PF; Ibrahim ZY; Singer B; Orr B; Donenwirth K; Brar PS
    J Am Acad Psychiatry Law; 1997; 25(2):173-81. PubMed ID: 9213289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic treatment of schizophrenics at risk for violence.
    Soyka M
    Pharmacopsychiatry; 2001 Jan; 34(1):43-4. PubMed ID: 11229622
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychopharmacology of Persistent Violence and Aggression.
    Meyer JM; Cummings MA; Proctor G; Stahl SM
    Psychiatr Clin North Am; 2016 Dec; 39(4):541-556. PubMed ID: 27836150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conceptual issues in the use of drugs for the treatment of aggression in man.
    Lion JR
    J Nerv Ment Dis; 1975 Feb; 160(2-1):76-82. PubMed ID: 235009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychopharmacology of violence with emphasis on schizophrenia, part 1: acute treatment.
    Citrome L
    J Clin Psychiatry; 2007 Jan; 68(1):163-4. PubMed ID: 17284144
    [No Abstract]   [Full Text] [Related]  

  • 10. Violence in schizophrenia and bipolar disorder.
    Volavka J
    Psychiatr Danub; 2013 Mar; 25(1):24-33. PubMed ID: 23470603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine is gold standard, but questions remain.
    Volavka J
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1201-4. PubMed ID: 22475059
    [No Abstract]   [Full Text] [Related]  

  • 12. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia with impulsive and aggressive behaviors.
    Lindenmayer JP; Kanellopoulou I
    Psychiatr Clin North Am; 2009 Dec; 32(4):885-902. PubMed ID: 19944890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating aggression in the psychiatric emergency service.
    Hughes DH; Kleespies PM
    J Clin Psychiatry; 2003; 64 Suppl 4():10-5. PubMed ID: 12672260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopharmacology of aggression in schizophrenia.
    Buckley P; Citrome L; Nichita C; Vitacco M
    Schizophr Bull; 2011 Sep; 37(5):930-6. PubMed ID: 21860038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
    Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
    Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. California State Hospital Violence Assessment and Treatment (Cal-VAT) guideline.
    Stahl SM; Morrissette DA; Cummings M; Azizian A; Bader S; Broderick C; Dardashti L; Delgado D; Meyer J; O'Day J; Proctor G; Rose B; Schur M; Schwartz E; Velasquez S; Warburton K
    CNS Spectr; 2014 Oct; 19(5):449-65. PubMed ID: 27358935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin for ultra resistant schizophrenia with aggressive behavior.
    Demily C; Franck N
    Schizophr Res; 2008 Mar; 100(1-3):349-50. PubMed ID: 18255272
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.